BetterLife Pharma (PVOTF) Short Interest Ratio & Short Volume → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free PVOTF Stock Alerts Add Compare Share Share Short InterestStock Analysis BetterLife Pharma Short Interest DataCurrent Short Volume70,100 sharesPrevious Short Volume15,100 sharesChange Vs. Previous Month+364.24%Dollar Volume Sold Short$10,865.50Short Interest Ratio / Days to Cover0.4Last Record DateMay 29, 2020Outstanding Shares171,414,000 sharesPercentage of Shares Shorted0.04%Today's Trading Volume198,200 sharesAverage Trading Volume52,703 sharesToday's Volume Vs. Average376% Short Selling BetterLife Pharma ? Sign up to receive the latest short interest report for BetterLife Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPVOTF Short Interest Over TimePVOTF Days to Cover Over TimePVOTF Percentage of Float Shorted Over Time Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. BetterLife Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/29/202070,100 shares $10,865.50 +364.2%N/A0.4 $0.16 5/15/202015,100 shares $2,627.40 +160.3%N/A0.1 $0.17 4/30/20205,800 shares $487.20 +163.6%N/A0.2 $0.08 4/15/20202,200 shares $203.94 -68.6%N/A0.2 $0.09 3/31/20207,000 shares $490.00 +311.8%N/A0.2 $0.07 3/13/20201,700 shares $123.25 -71.2%N/A0 $0.07 2/28/20205,900 shares $354.00 +78.8%N/A0.1 $0.06 2/14/20203,300 shares $299.64 +230.0%N/A0.1 $0.09 1/31/20201,000 shares $106.90 -77.8%N/A0 $0.11 1/15/20204,500 shares $483.30 +221.4%N/A0.1 $0.11 12/31/20191,400 shares $151.76 +100.0%N/A0 $0.11 PVOTF Short Interest - Frequently Asked Questions What is BetterLife Pharma's current short interest? Short interest is the volume of BetterLife Pharma shares that have been sold short but have not yet been closed out or covered. As of May 29th, investors have sold 70,100 shares of PVOTF short. Learn More on BetterLife Pharma's current short interest. Is BetterLife Pharma's short interest increasing or decreasing? BetterLife Pharma saw a increase in short interest during the month of May. As of May 29th, there was short interest totaling 70,100 shares, an increase of 364.2% from the previous total of 15,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BetterLife Pharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to BetterLife Pharma: Benitec Biopharma Inc. (0.50%), Synlogic, Inc. (0.53%), Alaunos Therapeutics, Inc. (9.51%), Nicox S.A. (0.00%), DermTech, Inc. (10.05%), BiomX Inc. (0.81%), ZIVO Bioscience, Inc. (4.24%), MEI Pharma, Inc. (0.34%), TherapeuticsMD, Inc. (0.41%), ATI Physical Therapy, Inc. (0.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.03 billion), Ecolab Inc. ($3.64 billion), Match Group, Inc. ($3.59 billion), Wayfair Inc. ($3.02 billion), Morgan Stanley ($2.87 billion), Tesla, Inc. ($2.69 billion), The Charles Schwab Co. ($2.64 billion), The Clorox Company ($2.50 billion), Zillow Group, Inc. ($1.86 billion), and International Flavors & Fragrances Inc. ($1.85 billion). View all of the most shorted stocks. What does it mean to sell short BetterLife Pharma stock? Short selling PVOTF is an investing strategy that aims to generate trading profit from BetterLife Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BetterLife Pharma? A short squeeze for BetterLife Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PVOTF, which in turn drives the price of the stock up even further. How often is BetterLife Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PVOTF, twice per month. The most recent reporting period available is May, 29 2020. More Short Interest Resources from MarketBeat Related Companies: BNTC Short Squeeze SYBX Short Squeeze TCRT Short Squeeze NICXF Short Squeeze DMTK Short Squeeze PHGE Short Squeeze ZIVO Short Squeeze MEIP Short Squeeze TXMD Short Squeeze ATIP Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PVOTF) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings